Publications and communications of Vincent Bours

Tan, A. K., Henry, A., Goffart, N., van Logtestijn, S., Bours, V., Hol, E. M., & Robe, P. (2024). Limited Effects of Class II Transactivator-Based Immunotherapy in Murine and Human Glioblastoma. Cancers, 16 (1), 193. doi:10.3390/cancers16010193

Kremer, C., Torneri, A., Libin, P. J. K., Meex, C., Hayette, M.-P., Bontems, S., Durkin, K. W., Artesi, M., Bours, V., Lemey, P., Darcis, G., Hens, N., & Meuris, C. (16 June 2023). Reconstruction of SARS-CoV-2 outbreaks in a primary school using epidemiological and genomic data. Epidemics, 44, 100701. doi:10.1016/j.epidem.2023.100701

Hoogstrate, Y., Draaisma, K., Ghisai, S. A., van Hijfte, L., Barin, N., de Heer, I., Coppieters, W., van den Bosch, T. P. P., Bolleboom, A., Gao, Z., Vincent, A. J. P. E., Karim, L., Deckers, M., Taphoorn, M. J. B., Kerkhof, M., Weyerbrock, A., Sanson, M., Hoeben, A., Lukacova, S., ... French, P. J. (10 April 2023). Transcriptome analysis reveals tumor microenvironment changes in glioblastoma. Cancer Cell, 41 (4), 678 - 692.e7. doi:10.1016/j.ccell.2023.02.019

Poulet, C., Swingland, J. T., Botta, V., Robe, P., Herens, C., Turkheimer, F., & Bours, V. (2023). Assessment of the normal cell contamination impact on tumour samples analysed with SNP arrays: The signal confusion nightmare. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/302224. doi:10.1101/2023.04.04.534870

Poulet, C.* , Debit, A.* , Josse, C., Jerusalem, G., Azencott, C.-A., Bours, V., & Van Steen, K. (2023). Assessing Random Forest self-reproducibility for optimal short biomarker signature discovery. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/303314. doi:10.1101/2023.03.29.534695
* These authors have contributed equally to this work.

Harvengt, J., Lumaka, A., Fasquelle, C., CABERG, J.-H., Mastouri, M., JANSSEN, A., Palmeira, L., & Bours, V. (22 March 2023). HIDEA syndrome: A new case report highlighting similarities with ROHHAD syndrome. Frontiers in Genetics, 14, 1137767. doi:10.3389/fgene.2023.1137767

Streel, S.* , Salmon, A.* , DHEUR, A., Bours, V., LEROI, N., Habran, L., Delbecque, K., Goffin, F., PLEYERS, C., Kakkos, A., Gonne, E., Seidel, L., Kridelka, F.* , & Gennigens, C.*. (02 March 2023). Diagnostic Performance of Immunohistochemistry Compared to Molecular Techniques for Microsatellite Instability and p53 Mutation Detection in Endometrial Cancer. International Journal of Molecular Sciences, 24 (5), 4866. doi:10.3390/ijms24054866
* These authors have contributed equally to this work.

Lumaka Zola, A., Fasquelle, C., Debray, F.-G., Alkan, S., Jacquinet, A., Harvengt, J., Boemer, F., Mulder, A., VAESSEN, S., Viellevoye, R., Palmeira, L., CHARLOTEAUX, B., Brysse, A., BULK, S., Rigo, V., & Bours, V. (16 February 2023). Rapid Whole Genome Sequencing Diagnoses and Guides Treatment in Critically Ill Children in Belgium in Less than 40 Hours. International Journal of Molecular Sciences, 24 (4), 4003. doi:10.3390/ijms24044003

NECHIFOR - POTORAC, I., Laterre, M., Malaise, O., NECHIFOR, V. A., Fasquelle, C., Colleye, O., Detrembleur, N., Verdin, H., Symoens, S., De Baere, E., Daly, A., Bours, V., Pétrossians, P., & Pintiaux, A. (28 January 2023). The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian Insufficiency. Journal of Clinical Medicine, 12 (3). doi:10.3390/jcm12030990

Meuris, C., Darcis, G., Orban, C., Hayette, M.-P., Meex, C., Desmecht, D., & Bours, V. (2023). Study of asymptomatic rectal carriage of Monkeypox virus in men who have sex with men, and immunological answer to vaccination, followed in Liège University Hospital. https://orbi.uliege.be/handle/2268/298473

Kasai, E. T., Gulbis, B., Ntukamunda, J. K., Bours, V., Batina Agasa, S., Marini Djang'Eing'A, R., Boemer, F., Katenga Bosunga, G., Ngbonda Dauly, N., Sokoni Vutseme, L. J., Boso Mokili, B., & Alworong’a Opara, J. P. (2023). Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update. Hematology, 28 (1). doi:10.1080/16078454.2023.2213043

Kambale-Kombi, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Minon, J.-M., Atoba Bokele, C., BOURS, V., Azerad, M.-A., Tonen-Wolyec, S., Kayembe Tshilumba, C., & Batina-Agasa, S. (December 2022). Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study. Hematology (Amsterdam, Netherlands), 27 (1), 590-595. doi:10.1080/16078454.2022.2074715

Garcia-Pelaez, J., Barbosa-Matos, R., Lobo, S., Dias, A., Garrido, L., Castedo, S., Sousa, S., Pinheiro, H., Sousa, L., Monteiro, R., Maqueda, J. J., Fernandes, S., Carneiro, F., Pinto, N., Lemos, C., Pinto, C., Teixeira, M. R., Aretz, S., Bajalica-Lagercrantz, S., ... Oliveira, C. (24 November 2022). Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes. The Lancet Oncology, 24 (1), 91-106. doi:10.1016/S1470-2045(22)00643-X

Cuypers, L., Dellicour, S., Hong, S. L., Potter, B. I., Verhasselt, B., Vereecke, N., Lambrechts, L., Durkin, K., Bours, V., Klamer, S., Bayon-Vicente, G., Vael, C., Ariën, K. K., De Mendonca, R., Soetens, O., Michel, C., Bearzatto, B., Naesens, R., Gras, J., ... Baele, G. (20 October 2022). Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants. Viruses, 14 (10), 2301. doi:10.3390/v14102301

Dheur, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kridelka, F., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kakkos, A. (October 2022). 2022-RA-193-ESGO Cost-effectiveness of molecular profiling for endometrial neoplasia: a single institution experience [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.203

Dubois, N., Berendsen, S., Tan, K., Schoysmans, L., Spliet, W., Seute, T., Bours, V., & Robe, P. (October 2022). STAT5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas. International Journal of Oncology, 61 (4). doi:10.3892/ijo.2022.5414

Salmon, A., Dheur, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kridelka, F., Kakkos, A., & Gennigens, C. (October 2022). Endometrial cancer: lymphovascular space invasion is a negative prognostic factor [Poster presentation]. 23rd European Congress on Gynaecological Oncology. doi:10.1136/ijgc-2022-esgo.264

DHEUR, A., Bours, V., De Cuypere, M., Delbecque, K., Gennigens, C., Goffin, F., Gonne, E., HERMESSE, J., Kakkos, A., Lovinfosse, P., PLEYERS, C., Salmon, A., & Kridelka, F. (29 September 2022). Defining prognostic risk groups amongst patients with endometrial cancer:respective role of 2009 figo stage and molecular profile [Poster presentation]. IGCS 2022, New York, United States.

Salmon, A., DHEUR, A., Bours, V., Delbecque, K., Gonne, E., PLEYERS, C., De Cuypere, M., Goffin, F., Lovinfosse, P., Kakkos, A., Kridelka, F., & Gennigens, C. (29 September 2022). Endometrial cancer: agreement between P53 immunohistochemistry and TP53 mutational analysis ? [Poster presentation]. IGCS 2022, New York, United States.

Kambale-Kombi, P., Marini Djang'Eing'A, R., ALWORONG’A OPARA, J., MINON, J., Sepulchre, E., Bours, V., FLOCH, A., PIRENNE, F., KAYEMBE TSHILUMBA, C., & BATINA AGASA, S. (August 2022). P-035: RED BLOOD CELL ALLOIMMUNIZATION IN SICKLE CELL DISEASE PATIENTS IN THE DEMOCRATIC REPUBLIC OF THE CONGO. HemaSphere, 6, 34-34. doi:10.1097/01.hs9.0000873036.01916.17

Kambale-Kombi, P., Djang'eing'a, R. M., Alworong'a Opara, J.-P., Mbo Mukonkole, J.-P., Bours, V., Tonen-Wolyec, S., Mbumba Lupaka, D.-M., Bome, L. B., Tshilumba, C. K., & Batina-Agasa, S. (14 July 2022). Renal Abnormalities among Sickle Cell Disease Patients in a Poor Management Setting: A Survey in the Democratic Republic of the Congo. Mediterranean Journal of Hematology and Infectious Diseases, 14 (1), 2022046. doi:10.4084/MJHID.2022.046

Kukor, L., BERTOLI, S., CREVECOEUR, J., Bours, V., & BULK, S. (21 April 2022). What does a Genetic Counsellor do in the University Hospital of Liège ? [Poster presentation]. BeSHG/NVHG Annual Genetics Symposium 2022.

BOEMER, F., JOSSE, C., LUIS, G., Di Valentin, E., Thiry, J., CELLO, C., CABERG, J.-H., DADOUMONT, C., HARVENGT, J., Lumaka, A., BOURS, V., & DEBRAY, F.-G. (18 February 2022). Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy. International Journal of Molecular Sciences, 23 (4), 2253. doi:10.3390/ijms23042253

Donneau, A.-F.* , Guillaume, M.* , BOURS, V., Dandoy, M., DARCIS, G., Desmecht, D., Diep, A. N., Fievez, L., Garigliany, M.-M., Gillain, N., Husson, E., Michel, F., MOUTSCHEN, M., Paridans, M., Pétré, B., Sabatel, C., Saegerman, C., Tytgat, A., Gillet, L.* , & Bureau, F.*. (2022). University population-based prospective cohort study of SARS-CoV- 2 infection and immunity (SARSSURV-ULiège): a study protocol. BMJ Open. doi:10.1136/bmjopen-2021-055721
* These authors have contributed equally to this work.

Freire, M. V., MARTIN, M., Thissen, R., Van Marcke, C., SEGERS, K., SEPULCHRE, E., LEROI, N., LETE, C., FASQUELLE, C., Radermacher, J., Gokburun, Y., COLLIGNON, J., Sacré, A., JOSSE, C., PALMEIRA, L., & BOURS, V. (2022). Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants. Frontiers in Oncology, 12, 835581. doi:10.3389/fonc.2022.835581

Thissen, R., ARTESI, M., Durkin, K., JOSSE, C., PALMEIRA, L., & BOURS, V. (24 December 2021). Comprehensive detection of homologous recombination deficiency by Nanopore sequencing [Poster presentation]. GIGA cancer day, Liège, Belgium.

Gordon, D. M., Beckers, P., CASTERMANS, E., Neggers, S. J., ROSTOMYAN, L., Bours, V., Pétrossians, P., Dideberg, V., Beckers, A., & Daly, A. (01 December 2021). Dutch Founder SDHB Exon 3 Deletion in Patients with Pheochromocytoma-Paraganglioma in South Africa. Endocrine Connections, 11 (1). doi:10.1530/EC-21-0560

VALDES SOCIN, H. G., ANDRIS, C., CROMMEN, J., PETROSSIANS, P., BOURS, V., & DEBRAY, F.-G. (December 2021). It’s all in their eyes: a three-generation family with branchio-oculo-facial syndrome (BOFS) reveals a heterozygous novel mutation in TFAP2A gene. Acta Clinica Belgica, 2 (76), 27-29.

VALDES SOCIN, H. G., LIBIOULLE, C., PETIGNOT, S., BETEA, D., PINTIAUX, A., DIVE, D., DEBRAY, F.-G., BOURS, V., & PETROSSIANS, P. (17 September 2021). Male and female hypogonadotropic hypogonadism associated with two novel non sense heterozygous mutations of Klotho beta gene (KLB) [Poster presentation]. Belgian Society of Genetics, Bruxelles, Belgium.

Poncin, A., Onesti, C. E., JOSSE, C., Boulet, D., Thiry, J., Bours, V., & Jerusalem, G. (August 2021). Immunity and Breast Cancer: Focus on Eosinophils. Biomedicines, 9 (9), 1087. doi:10.3390/biomedicines9091087

LETE, C., Ameye, G., BECKERS, P., Michaux, L., BOURS, V., JAMAR, M., De Bie, J., Dewaele, B., & MENTEN, C. (July 2021). CASE REPORT: the use of optical genome mapping (Bionano) to understand a complex mechanism of a KMT2A rearrangement in an AML case [Poster presentation]. 13th European Cytogenomics Conference.

LETE, C., FERNANDEZ CARAZO, R., MENTEN, C., BECKERS, P., KOOPMANSCH, B., FRANKE, S., DE PRIJCK, B., JAMAR, M., LAMBERT, F., & BOURS, V. (July 2021). A case of early-T-cell precursor acute lymphoblastic leukemia with e6a2 BCR-ABL1 fusion transcript [Poster presentation]. 13th European Cytogenomics Conference.

Durkin, K., Artesi, M., VAN DEN BROEKE, A., Bours, V., Hahaut, V., & Georges, M. (21 June 2021). Pooled crispr inverse pcr sequencing (pcip-seq): simultaneous sequencing of viral insertion points and the integrated viral genomes with long reads.

Van Campenhout, C., De Mendonça, R., Alexiou, B., De Clercq, S., Racu, M.-L., Royer-Chardon, C., Rusu, S., Van Eycken, M., ARTESI, M., Durkin, K., Mardulyn, P., BOURS, V., Decaestecker, C., Remmelink, M., Salmon, I., & D'Haene, N. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Genome Sequencing from Post-Mortem Formalin-Fixed, Paraffin-Embedded Lung Tissues. The Journal of Molecular Diagnostics. doi:10.1016/j.jmoldx.2021.05.016

Uyisenga, J. P.* , Debit, A.* , Poulet, C., Frères, P., Poncin, A., Thiry, J., Mutesa, L., Jerusalem, G., Bours, V.* , & JOSSE, C.*. (03 June 2021). Differences in plasma microRNA content impair microRNA-based signature for breast cancer diagnosis in cohorts recruited from heterogeneous environmental sites. Scientific Reports, 11 (1), 11698. doi:10.1038/s41598-021-91278-0
* These authors have contributed equally to this work.

BECKERS, P., CABERG, J.-H., DIDEBERG, V., Dangouloff, T., den Dunnen, J. T., BOURS, V., Servais, L., & BOEMER, F. (04 February 2021). Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon‑skipping therapy. Scientific Reports, 11, 3011. doi:10.1038/s41598-021-82725-z

Artesi, M.* , Hahaut, V.* , Cole, B.* , Lambrechts, L., Ashrafi, F., Marçais, A., Hermine, O., Griebel, P., Arsic, N., van der Meer, F., Burny, A., Bron, D., BIANCHI, E., DELVENNE, P., BOURS, V., Charlier, C., Georges, M., Vandekerckhove, L.* , Van den Broeke, A.* , & Durkin, K.*. (2021). PCIP-seq: simultaneous sequencing of integrated viral genomes and their integration sites with long reads. Genome Biology, 22, 97. doi:10.1186/s13059-021-02307-0
* These authors have contributed equally to this work.

BOEMER, F., Caberg, J.-H., Beckers, P., Dideberg, V., di Fiore, S., Bours, V., Marie, S., Dewulf, J., Marcelis, L., Deconinck, N., Daron, A., Blasco-Perez, L., Tizzano, E., Hiligsmann, M., Lombet, J., Pereira, T., Lopez-Granados, L., Shalchian-Tehran, S., van Assche, V., ... Servais, L. (2021). Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. Scientific Reports, 11 (1), 19922. doi:10.1038/s41598-021-99496-2

Bollen, N., Artesi, M., Durkin, K., Hong, S. L., Potter, B., Boujemla, B., Vanmechelen, B., Martí-Carreras, J., Wawina-Bokalanga, T., Meex, C., Bontems, S., Hayette, M.-P., André, E., Maes, P., Bours, V., Baele, G., & Dellicour, S. (2021). Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020. Scientific Reports, 11 (1), 18580. doi:10.1038/s41598-021-97667-9

Butera, Y., Mukantwari, E., Artesi, M., Umuringa, J. D. A., O'Toole, Á. N., Hill, V., Rooke, S., Hong, S. L., Dellicour, S., Majyambere, O., Bontems, S., Boujemla, B., Quick, J., Resende, P. C., Loman, N., Umumararungu, E., Kabanda, A., Murindahabi, M. M., Tuyisenge, P., ... Rujeni, N.*. (2021). Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity. Nature Communications, 12 (1), 5705. doi:10.1038/s41467-021-25985-7
* These authors have contributed equally to this work.

Dellicour, S., Durkin, K., Hong, S., Vanmechelen, B., Marti-Carreras, J., Gill, M., Meex, C., Bontems, S., André, E., Gilbert, M., Walker, C., De Maio, N., Hadfield, J., Hayette, M.-P., Bours, V., Wawina-Bokalanga, T., Artesi, M., Baele, G., Maes, P., & Faria, N. R. (2021). A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages. Molecular Biology and Evolution. doi:10.1093/molbev/msaa284

Hoogstrate, Y., Ghisai, S. A., de Wit, M., de Heer, I., Draaisma, K., van Riet, J., van de Werken, H. J. G., Bours, V., Buter, J., Vanden Bempt, I., Eoli, M., Franceschi, E., Frenel, J.-S., Gorlia, T., Hanse, M. C., Hoeben, A., Kerkhof, M., Kros, J. M., Leenstra, S., ... French, P. J. (2021). The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis. Neuro-Oncology. doi:10.1093/neuonc/noab231

Kambale-Kombi, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Minon, J.-M., BOEMER, F., BOURS, V., Tonen-Wolyec, S., Kayembe Tshilumba, C., & Batina-Agasa, S. (January 2021). Management of sickle cell disease: current practices and challenges in a northeastern region of the Democratic Republic of the Congo. Hematology, 26 (1), 199-205. doi:10.1080/16078454.2021.1880752

Maclot, F., Bontems, S., Meex, C., Artesi, M., Beckers, P., Bours, V., Durkin, K., & Hayette, M.-P. (2021). Development of a multiplex RT-qPCR using the drop out strategy to screen the SARS-CoV-2 South African 501Y.V2 variant. The Journal of infection, 83 (1), 19-e21. doi:10.1016/j.jinf.2021.04.035

Meuris, C., Kremer, C., Geerinck, A., Locquet, M., Bruyère, O., Defêche, J., Meex, C., Hayette, M.-P., Duchene, L., Dellot, P., Azarzar, S., Maréchal, N., Sauvage, A.-S., Frippiat, F., Giot, J.-B., Léonard, P., Fombellida, K., Moutschen, M., Durkin, K., ... Darcis, G. (2021). Transmission of SARS-CoV-2 After COVID-19 Screening and Mitigation Measures for Primary School Children Attending School in Liège, Belgium. JAMA Network Open, 4 (10), 2128757. doi:10.1001/jamanetworkopen.2021.28757

Van Den Bogaert, K., Lannoo, L., Brison, N., Gatinois, V., Baetens, M., Blaumeiser, B., BOEMER, F., Bourlard, L., Bours, V., De Leener, A., De Rademaeker, M., Désir, J., Dheedene, A., Duquenne, A., Fieremans, N., Fieuw, A., GATOT, J.-S., Grisart, B., Janssens, K., ... Vermeesch, J. R. (2021). Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genetics in Medicine, 23 (6), 1137-1142. doi:10.1038/s41436-021-01101-4

Wislet-Gendebien, S., Poulet, C., Neirinckx, V., Hennuy, B., Swingland, J. T., Laudet, E., Sommer, L., Shakova, O., Bours, V., & Rogister, B. (2021). Correction: In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow. PLoS ONE, 16 (9), 0256477. doi:10.1371/journal.pone.0256477

Onesti, C. E., JOSSE, C., Boulet, D., Bours, V., & JERUSALEM, G. (2020). High plasmatic levels of IL-4 and IL- 13 are associated with recurrence and worse survival in breast cancer. Tumori Journal.

ONESTI, C. E., JOSSE, C., Beaumecker, B., Boulet, D., Thiry, J., BOURS, V., & JERUSALEM, G. (2020). The relative eosinophil count in breast cancer as an emerging prognostic biomarker. European Journal of Cancer. doi:10.1016/S0959-8049(20)30766-8

HARVENGT, J., ALKAN, S., Florkin, B., BULK, S., & Bours, V. (June 2020). POP1-Skeletal dysplasias : description of two new families [Poster presentation]. European Human Genetics Virtual Conference 2020.

DOCAMPO MARTINEZ, E., MARTIN, M., Marnette, J., & Bours, V. (06 March 2020). LTBP3 mutation identified in a patient with a severe valvular disease [Poster presentation]. 20th Annual Meeting of the Belgian Society of Human Genetics.

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012

HARVENGT, J., GERNAY, C., Mastouri, M., FARHAT, N., LEBRETHON, M.-C., Seghaye, M.-C., & Bours, V. (2020). ROHHAD(NET) Syndrome: Systematic review of the clinical timeline and recommendations for diagnosis and prognosis. Journal of Clinical Endocrinology and Metabolism. doi:10.1210/clinem/dgaa247

Kambale-Kombi, P., Marini Djang'Eing'A, R., Alworong'a Opara, J.-P., Wa Inena, G. I., Falay Sadiki, D., BOEMER, F., BOURS, V., Tshilumba, C. K., & Batina-Agasa, S. (2020). Comorbidity of sickle cell trait and albinism: a cross-sectional survey in the Democratic Republic of the Congo. Pan African Medical Journal, 35, 127. doi:10.11604/pamj.2020.35.127.21113

ONESTI, C. E., JOSSE, C., Boulet, D., Thiry, J., Beaumecker, B., BOURS, V., & JERUSALEM, G. (2020). Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse. Oncoimmunology. doi:10.1080/2162402X.2020.1761176

Uyisenga, J., Butera, Y., Debit, A., JOSSE, C., Ainhoa, C. C., Karinganire, E., Cyuzuzo, A. P., Umurungi, N., Kalinijabo, Y., Uwimana, S., Mutesa, L., & Bours, V. (2020). Prevalence of Histological Characteristics of Breast Cancer in Rwanda in Relation to Age and Tumor Stages. Hormones and Cancer. doi:10.1007/s12672-020-00393-3

ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., Poulet, C., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism differentiates breast cancer patients from healthy controls but does not predict outcome. Annals of Oncology.

VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., BOURS, V., & BECKERS, A. (2019). A novel rare case of normosmic congenital hypogonadotropic hypogonadism associating a GnRHR and a KISS1R variants. In Endocrine Abstracts - ECE 2019.

Debit, A., Poulet, C., JOSSE, C., Azencott, C.-A., Jerusalem, G., Van Steen, K., & BOURS, V. (15 March 2019). TOWARDS AN ACCURATE CANCER DIAGNOSIS MODELIZATION:COMPARISON OF RANDOM FOREST STRATEGIES [Poster presentation]. 19th BeSHG meeting 15th March 2019 Liege, Belgium, Liege, Belgium.

HARVENGT, J., Boros, E., BULK, S., & Bours, V. (15 March 2019). COL1A2 mutation in a case of isolated short stature [Poster presentation]. 19th Annual Meeting of the Belgian Society of Human Genetics, Liège, Belgium.

Latge, G., Poulet, C., JOSSE, C., JERUSALEM, G., & Bours, V. (15 March 2019). Role of DNA methylation in INK4a-ARF-INK4b locus expression in breast cancer [Poster presentation]. 19th Meeting of the Belgian Society of Human Genetics, Liège, Belgium.

Daly, A., Cano, D. A., Venegas, E., PETROSSIANS, P., Dios, E., CASTERMANS, E., Flores-Martinez, A., Bours, V., Beckers, A., & Soto, A. (2019). AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center. Endocrine Connections. doi:10.1530/EC-19-0027

Berendsen, S., Spliet, W. G. M., Geurts, M., Van Hecke, W., Seute, T., Snijders, T. J., Bours, V., Bell, E. H., Chakravarti, A., & Robe, P. (2019). Epilepsy associates with decreased HIF-1α/STAT5b signaling in glioblastoma. Cancers, 11 (1). doi:10.3390/cancers11010041

Berendsen, S., van Bodegraven, E., Seute, T., Spliet, W. G. M., Geurts, M., Hendrikse, J., SCHOYSMAN, L., Huiszoon, W. B., Varkila, M., Rouss, S., Bell, E. H., Kroonen, J., Chakravarti, A., Bours, V., Snijders, T. J., & Robe, P. (2019). Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates. PLoS ONE, 14 (10), 0222717. doi:10.1371/journal.pone.0222717

JADOT, V., SEGERS, K., Bours, V., KOHNEN, L., HONORE, P., MARTIN, M., DE FLINES, J., MUTIJIMA NZARAMBA, E., & LECLERCQ, P. (2019). Cancer gastrique diffus héréditaire Série de 8 patients appartenant à une même famille et revue de la littérature. Revue Médicale de Liège, 74 (3), 134-138.

Lion, L., LECLERCQ, P., Plomteux, O., & Bours, V. (2019). Etude des risques oncologiques associés au syndrome de Lynch en région liégeoise. Revue Médicale de Liège, 74 (9), 479-483.

ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. Journal of Translational Medicine, 17, 239. doi:10.1186/s12967-019-1984-2

ONESTI, C. E., JOSSE, C., Poncin, A., FRERES, P., Poulet, C., BOURS, V., & JERUSALEM, G. (2018). Predictive and prognostic role of peripheral blood eosinophil count in triple-negative and hormone receptor-negative/HER2-positive breast cancer patients undergoing neoadjuvant treatment. Oncotarget. doi:10.18632/oncotarget.26120

Debit, A., JOSSE, C., JERUSALEM, G., BOURS, V., & Poulet, C. (13 September 2018). Towards an accurate cancer diagnosis modelization:Comparison of Random Forest strategies [Poster presentation]. JOINT MEETING GIGA-CANCER DAY 2018 / EDT-CANCEROLOGY, Liege, Belgium.

ONESTI, C. E., JOSSE, C., PONCIN, A., FRERES, P., Poulet, C., BOURS, V., & JERUSALEM, G. (13 September 2018). Predictive and prognostic role of peripheral blood eosinophil count in triple negative and hormone receptor negative/HER2 positive breast cancers patients undergoing neoadjuvant treatment [Paper presentation]. GIGA-Cancer Day 2018 / EDT-Cancerology Vascular landscape and (pre)metastatic niche in cancer biology.

Parotte, M.-C., CASTERMANS, E., Bours, V., Beckers, A., & VALDES SOCIN, H. G. (September 2018). Hypercalcémie familiale bénigne révélée par des crises de colique néphrétique : description d'une nouvelle mutation du calcium sensing receptor (CasR) [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., Debray, F.-G., HARVENGT, J., LIBIOULLE, C., DIDEBERG, V., Bours, V., & Beckers, A. (September 2018). CHD7 impliqué dans l'hypogonadisme hypogonadotrope avec ou sans anosmie : description de 3 patients et de 3 nouvelles mutations [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., Geenen, V., CORMAN, V., DEBRAY, F.-G., Dideberg, V., T'sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Burlacu, C., VROONEN, L., Bours, V., ... Beckers, A. (September 2018). Etude multicentrique belge chez 56 patients avec hypogonadisme hypogonadotrope congénital (HHC) : caractérisation des anomalies génétiques et cérébrales [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., LIBIOULLE, C., Tsjoen, G., DEBRAY, F.-G., Bours, V., & Beckers, A. (September 2018). TAC3 et TACR3 impliqués dans l'hypogonadisme hypogonadotrope normosmique : description de trois patients avec des nouvelles mutations [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France.

VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., PINTIAUX, A., JONAS, C., Parent, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Bours, V., Maiter, D., & Beckers, A. (May 2018). The first Belgian series of 56 patients with congenital hypogonadotropic hypogonadism (CHH) : genetics and brain abnormalities [Poster presentation]. 20th European Congress of Endocrinology.

VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., BOURS, V., Maiter, D., & BECKERS, A. (2018). Brain imaging and genetics in patients with congenital hypogonadotropic hypogonadism: a multicenter Belgian study. In J. O. Jorgensen, NENEG Abstract Book Communications (pp. 64). Aarhus, Denmark: Pfizer.

Daly, A.* , CASTERMANS, E.* , Oudijk, L., Guitelman, M. A., BECKERS, P., NECHIFOR, I., Neggers, S. J. C. M. M., SACRE, N., Van der Lely, A. J., Bours, V., de Herder, W. W., & Beckers, A. (13 March 2018). Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions. Endocrine-Related Cancer, 25 (5), 37–42. doi:10.1530/ERC-18-0065
* These authors have contributed equally to this work.

BERTOLI, S., VAN CASTEREN, L., Bours, V., & BULK, S. (16 February 2018). The cardiogenetics consultation : an inventorisation of the Liege population [Poster presentation]. Meeting of the Belgian Society for Human Genetics (BeSHG) : "The Epigenome in development and disease", Ghent, Belgium.

HARVENGT, J., LIBIOULLE, C., Debray, F.-G., DIDEBERG, V., Bours, V., & VALDES SOCIN, H. G. (16 February 2018). Brain MRI abnormalities and genetic results in a series of 30 patients with congenital isolated hypogonadotrophic hypogonadism (CIHH) [Poster presentation]. Meeting of the Belgian Society for Human Genetics (BeSHG) : "The Epigenome in development and disease", Ghent, Belgium.

KUKOR, L., BERTOLI, S., Bours, V., BULK, S., & DOCAMPO MARTINEZ, E. (16 February 2018). Ehlers-Danlos syndrome in the University Hospital of Liege [Poster presentation]. Meeting of the Belgian Society for Human Genetics (BeSHG) : "The Epigenome in development and disease", Ghent, Belgium.

Costanza, B., Turtoi, A., Bellahcene, A., Hirano, T., Peulen, O., Blomme, A., Hennequiere, J., MUTIJIMA NZARAMBA, E., Boniver, J., Meuwis, M.-A., JOSSE, C., KOOPMANSCH, B., SEGERS, K., Yokobori, T., Fahmy, K., Thiry, M., COIMBRA MARQUES, C., Garbacki, N., Colige, A., ... Castronovo, V. (2018). Innovative methodology for the identification of soluble biomarkers in fresh tissues. Oncotarget, 9 (12), 10665-10680. doi:10.18632/oncotarget.24366

Freres, P., Bouznad, N., Servais, L., JOSSE, C., Wenric, S., Poncin, A., Thiry, J., Moonen, M., Oury, C., Lancellotti, P., Bours, V., & Jerusalem, G. (2018). Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients. BMC Cancer, 18 (1). doi:10.1186/s12885-018-4015-4

Latge, G., Poulet, C., Bours, V., JOSSE, C., & Jerusalem, G. (2018). Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers. International Journal of Molecular Sciences, 19 (1). doi:10.3390/ijms19010123

VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., BOURS, V., & BECKERS, A. (2018). Le Syndrome de Kallmann: un vieux syndrome revisité par la génétique. Urologic, 14, 1-7.

VALDES SOCIN, H. G., DEBRAY, F.-G., LIBIOULLE, C., DIDEBERG, V., BOURS, V., & Beckers, A. (2017). Syndrome de charge atypique avec hypogonadisme hypogonadotrope anosmique : description de 2 nouvelles mutations. In Annales d'Endocrinologie - abstract book.

Debit, A., Wenric, S., JOSSE, C., Van Steen, K., & Bours, V. (May 2017). Normalization and correction for batch effects via RUV for RNA-seq data: practical implications for Breast Cancer Research [Poster presentation]. European Human Genetics Conference ESHG 2017, Copenhagen, Denmark.

Wenric, S., El Guendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., Olivier, F., Jossa, V., JERUSALEM, G., JOSSE, C., & BOURS, V. (May 2017). Transcriptome wide analysis of natural antisense transcripts shows potential role in breast cancer [Poster presentation]. 50th meeting of the European Society of Human Genetics, Copenhagen, Denmark.

BOEMER, F., Fasquelle, C., D'OTREPPE DE BOUVETTE, S., JOSSE, C., DIDEBERG, V., SEGERS, K., GUISSARD, V., CAPRARO, V., Debray, F.-G., & Bours, V. (2017). A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases. Scientific Reports, 7 (1), 17641. doi:10.1038/s41598-017-18038-x

Potorac, I., CORMAN, V., Manto, F., Dassy, S., SEGERS, K., THIRY, A., Bours, V., Daly, A., & Beckers, A. (2017). Genetic predisposition to breast cancer occuring in a male-to-female transsexual patient. In Abstract book : Symposium "Perspectives in Endocrinology".

Rostomyan, L., Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., de Herder, W., Naves, L., Metzger, D., Cuny, T., Rabl, W., Shah, N., Jaffrain-Rea, M., Zatelli, M., Faucz, F., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... Beckers, A. (2017). Somatic mosaicism is implicated in the etiology of XLAG syndrome. In Abstract book : Symposium "Perspectives in Endocrinology".

Sticca, T., CABERG, J.-H., Wenric, S., Poulet, C., HERENS, C., JAMAR, M., Josse, C., El Guendi, S., MAX, S., BEGUIN, Y., GOTHOT, A., CAERS, J., & Bours, V. (2017). Genomic Studies of Multiple Myeloma Reveal an Association between X Chromosome Alterations and Genomic Profile Complexity. Genes, Chromosomes and Cancer, 56, 18-27. doi:10.1002/gcc.22397

Wenric, S., ElGuendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., OLIVIER, F., Jossa, V., Jerusalem, G., JOSSE, C., & Bours, V. (2017). Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer. Scientific Reports, 7 (1), 17452. doi:10.1038/s41598-017-17811-2

Wenric, S.* , Sticca, T.* , CABERG, J.-H., Josse, C., Fasquelle, C., HERENS, C., JAMAR, M., MAX, S., GOTHOT, A., CAERS, J., & Bours, V. (2017). Exome copy number variation detection: Use of a pool of unrelated healthy tissue as reference sample. Genetic Epidemiology, 41, 35-40. doi:10.1002/gepi.22019
* These authors have contributed equally to this work.

VALDES SOCIN, H. G., CORMAN, V., LIBIOULLE, C., Debray, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Hypogonadisme hypogonadotrope anosmique associé à une nouvelle mutation hétérozygote c.937C>T, p.His314Tyr de l'isoforme IIIb du gène FGR1. In Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie.

VALDES SOCIN, H. G., DEBRAY, F.-G., LIBIOULLE, C., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., VROONEN, L., DIDEBERG, V., Bours, V., & BECKERS, A. (2016). Caractérisation clinique, neuroendocrinienne, génétique et résultats thérapeutiques dans le syndrome de Kallmann et de l'hypogonadisme normosmique idiopathique : expérience liégeoise. In Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie.

Potorac, I., CORMAN, V., Manto, F., Dassy, S., SEGERS, K., THIRY, A., Bours, V., Daly, A., & BECKERS, A. (May 2016). Genetic predisposition to breast cancer occurring in a male-to-female transsexual patient [Poster presentation]. European Congress of Endocrinology, Munich, Germany. doi:10.1530/endoabs.41.EP615

Rostomyan, L., Mangupli, R., CASTERMANS, E., CABERG, J.-H., Camperos, P., Krivoy, J., Cuaruo, E., Bours, V., Daly, A., & BECKERS, A. (May 2016). Combined treatment with octreotide LAR and pegvisomant in patients with gigantism – acromegaly: clinical evaluation and genetic screening [Poster presentation]. European Congress of Endocrinology, Munich, Germany. doi:10.1530/endoabs.41.EP889

Daly, A., Yuan, B., Fina, F., CABERG, J.-H., Trivellin, G., Rostomyan, L., de Herder, W. W., Naves, L. A., Metzger, D., Cuny, T., Rabl, W., Shah, N. S., Jaffrain-Rea, M.-L., Zatelli, M. C., Faucz, F. R., CASTERMANS, E., Nanni-Metellus, I., Lodish, M., Muhammad, A., ... BECKERS, A. (02 March 2016). Somatic mosaicism underlies X-linked acrogigantism (XLAG) syndrome in sporadic male subjects. Endocrine-Related Cancer, 23 (4), 221-233. doi:10.1530/ERC-16-0082

Castinetti, F.* , Daly, A.* , Stratakis, C., CABERG, J.-H., CASTERMANS, E., Trivellin, G., Rostomyan, L., Saveanu, A., Jullien, N., Reynaud, R., Barlier, A., Bours, V., Brue, T., & Beckers, A. (2016). GPR101 mutations are not a frequent cause of congenital isolated growth hormone deficiency. Hormone and Metabolic Research, 1-5. doi:10.1055/s-0042-100733
* These authors have contributed equally to this work.

CORMAN, V.* , Potorac, I.* , Manto, F., Dassy, S., SEGERS, K., THIRY, A., Bours, V., Daly, A., & BECKERS, A. (2016). Breast cancer in a male to female transsexual patient with a BRCA2 mutation. Endocrine-Related Cancer, 23 (5), 391-397. doi:10.1530/ERC-16-0057
* These authors have contributed equally to this work.

Daly, A., Lysy, P., Defilles, C., Rostomyan, L., Mohamed, A., CABERG, J.-H., Raverot, V., CASTERMANS, E., Marbaix, E., Maiter, D., Brunelle, C., Trivellin, G., Stratakis, C. A., BOURS, V., Raftopoulos, C., Beauloye, V., Barlier, A., & BECKERS, A. (2016). Growth hormone releasing hormone excess and blockade in X-LAG syndrome. Endocrine-Related Cancer. doi:10.1530/ERC-15-0478

FRERES, P., PONCIN, A., MOONEN, M., Josse, C., Oury, C., BOURS, V., LANCELLOTTI, P., & JERUSALEM, G. (2016). La cardiotoxicité des traitements anti-cancéreux. Revue Médicale de Liège, 71 (9), 382-387.

Jaspar, M., Manard, M., DIDEBERG, V., Bours, V., Maquet, P., & Collette, F. (2016). Influence of COMT Genotype on Antero-Posterior Cortical Functional Connectivity Underlying Interference Resolution. Cerebral Cortex, 26, 498-509. doi:10.1093/cercor/bhu188

VALDES SOCIN, H. G., LIBIOULLE, C., Debray, F.-G., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., Burlacu, C., JONAS, C., Maiter, D., T'Sjoen, G., Poppe, K., Brachet, C., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Neuroendocrine phenotype, genetics and hormonal treatment outcome in idiopathic normosmic hypogonadism and Kallman syndrome patients : A multicenter Belgian Study. In Acta Clinical Belgica.

VALDES SOCIN, H. G., Palmeira, L., Burlacu, M., Daly, A., Bours, V., & Beckers, A. (2016). Cancer thyroïdien familial non médullaire : actualités cliniques et génétiques. Revue Médicale de Liège, 71 (12), 557-561.

Willems, M., Dubois, N., Musumeci, L., Bours, V., & Robe, P. (2016). IkappaBzeta: an emerging player in cancer. Oncotarget, 7 (40), 66310-66322. doi:10.18632/oncotarget.11624

Freres, P.* , Wenric, S.* , BOUKERROUCHA, M., Fasquelle, C., Thiry, J., Bovy, N., Struman, I., Geurts, P., COLLIGNON, J., SCHROEDER, H., KRIDELKA, F., LIFRANGE, E., Jossa, V., Bours, V.* , Josse, C.* , & JERUSALEM, G.*. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. doi:10.18632/oncotarget.6786
* These authors have contributed equally to this work.

CASTERMANS, E., Auriemma, R., Rostomyan, L., SACRE, N., CABERG, J.-H., Bours, V., Daly, A., & Beckers, A. (2015). Etude moléculaire du gène AIP sur plus de 1400 individus atteints d'adénome hypophysaire. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

Potorac, I., BETEA, D., MALAISE, O., Daniel, S., CASTERMANS, E., Bours, V., Daly, A., & Beckers, A. (2015). Une forme compliquée d'hypercalcémie hypocalciurique familiale. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

Potorac, I., BETEA, D., PETROSSIANS, P., CASTERMANS, E., HAMOIR, E., Labasse, J., Bours, V., Daly, A., & Beckers, A. (2015). Hyperparathyroïdie primaire familiale isolée - corrélation génotype - phénotype des mutations MEN 1? In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

VALDES SOCIN, H. G., Pintiaux, A., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2015). Hypogonadisme hypogonadotrope normosmique familial : identification d'une nouvelle mutation c.1664-2A> T du gène FGFR1. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., LANCELLOTTI, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouseplatelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada.

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., Lancellotti, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouse platelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada.

Boukerroucha, M., Josse, C., SEGERS, K., El Guendi, S., FRERES, P., JERUSALEM, G., & Bours, V. (26 March 2015). BRCA1 germline mutation and glioblastoma development: report of cases. BMC Cancer, 15, 181. doi:10.1186/s12885-015-1205-1

Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Thiry, M., Compère, P., BOURS, V., Lancellotti, P., & Oury, C. (27 January 2015). Bacterial DNA mimetics activate platelets and promote thrombosis via CLEC-2 [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium.

Beckers, A.* , Lodish, M.* , Trivellin, G., Rostomyan, L., Lee, M., Faucz, F., Yuan, B., Choong, C., CABERG, J.-H., Verrua, E., Naves, L. A., Cheetham, T., Young, J., Lysy, P., PETROSSIANS, P., Cotterill, A., Shah, N. S., Metzger, D., CASTERMANS, E., ... Stratakis, C.*. (2015). X-linked acrogigantism syndrome : Clinical Profile and Therapeutic responses. Endocrine-Related Cancer, 22, 353-367. doi:10.1530/ERC-15-0038
* These authors have contributed equally to this work.

Boukerroucha, M., Josse, C., El Guendi, S., Boujemla, B., Freres, P., Marée, R., Wenric, S., SEGERS, K., COLLIGNON, J., Jerusalem, G., & Bours, V. (2015). Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers. BMC Cancer, 15 (1), 755. doi:10.1186/s12885-015-1740-9

Bovy, N., Blomme, B., Freres, P., Dederen, S., Nivelles, O., Lion, M., Carnet, O., Martial, J., Noël, A., Thiry, M., Jerusalem, G., Josse, C., Bours, V., Tabruyn, S., & Struman, I. (2015). Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. doi:10.18632/oncotarget.3520

DIDEBERG, V., SEGERS, K., KOOPMANSCH, B., LAMBERT, F., & Bours, V. (2015). PHARMACOGENOMIQUE ET MEDECINE PERSONNALISEE : VERS UN SCREENING SYSTEMATIQUE DE LA POPULATION ? Revue Médicale de Liège, 70 (5-6), 251-6.

Jaspar, M., DIDEBERG, V., Bours, V., Maquet, P., & Collette, F. (2015). Modulating effect of COMT Val158Met polymorphism on interference resolution during a working memory task. Brain and Cognition, 95, 7-18. doi:10.1016/j.bandc.2015.01.013

JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276.

Sticca, T., Wenric, S., CABERG, J.-H., MAX, S., GOTHOT, A., CAERS, J., & Bours, V. (2015). Genomic study of multiple myeloma based on SNP-aCGH and high-throughput exome sequencing.

Jaspar, M., Genon, S., Muto, V., Meyer, C., Manard, M., DIDEBERG, V., Bours, V., Salmon, E., Maquet, P., & Collette, F. (2014). Modulating effect of COMT genotype on the brain regions underlying proactive control process during inhibition. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 50, 148-161. doi:10.1016/j.cortex.2013.06.003

Trivellin, G.* , Daly, A.* , Faucz, F. R., Yuan, B., Rostomyan, L., Larco, D. O., Schernthaner-Reiter, M. H., Szarek, E., Leal, L. F., CABERG, J.-H., CASTERMANS, E., Villa, C., Dimopoulos, A., Chittiboina, P., Xekouki, P., Shah, N. S., Metzger, D., Lysy, P. A., Ferrante, E., ... Stratakis, C. A.*. (2014). Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation. New England Journal of Medicine. doi:10.1056/NEJMoa1408028
* These authors have contributed equally to this work.

Uwineza, A., CABERG, J.-H., Hitayezu, J., JAMAR, M., DIDEBERG, V., Rusingiza, E. K., Bours, V., Mutesa, L., & Hellin, A.-C. (2014). Array-CGH analysis in Rwandan patients presenting development delay/intellectual disability with multiple congenital anomalies. BMC Medical Genetics, 15 (1), 79. doi:10.1186/1471-2350-15-79

VALDES SOCIN, H. G., Rubio Almanza, M., Tome Fernandez-Ladreda, M., Debray, F.-G., Bours, V., & Beckers, A. (2014). Reproduction, smell, and neurodevelopmental disorders: genetic defects in different hypogonadotropic hypogonadal syndromes. Frontiers in Endocrinology, 5, 109. doi:10.3389/fendo.2014.00109

Wenric, S., Freres, P., Josse, C., Bours, V., & Jerusalem, G. (09 December 2013). A miRNA expression based diagnostic tool for breast cancer using random forests [Poster presentation]. Benelux Bioinformatics Conference 2013.

Ziegler, E., Foret, A., Mascetti, L., Muto, V., Le Bourdiec-Shaffii, A., Stender, J., Balteau, E., DIDEBERG, V., Bours, V., Maquet, P., & Phillips, C. (2013). Altered white matter architecture in BDNF Met carriers. PLoS ONE. doi:10.1371/journal.pone.0069290

Phillips, C., Foret, A., Mascetti, L., Muto, V., Shaffi-Le Bourdiec, A., Stender, J., DIDEBERG, V., BOURS, V., Maquet, P., & Ziegler, E. (19 June 2013). Connectome-based classification of BDNF Met allele carriers [Paper presentation]. 19th Annual Meeting of the Organization for Human Brain Mapping, Seattle, United States.

Ziegler, E., Foret, A., Mascetti, L., Muto, V., Le Bourdiec-Shaffi, A., Stender, J., Balteau, E., DIDEBERG, V., BOURS, V., Maquet, P., & Phillips, C. (June 2013). Connectome-based classification of BDNF Met allele carriers [Poster presentation]. 19th Annual Meeting of the Organization for Human Brain Mapping, Seattle, United States.

Wenric, S., JOSSE, C., Fasquelle, C., Poulet, C., Sticca, T., Boukerroucha, M., JERUSALEM, G., & Bours, V. (15 March 2013). Exome sequencing of tumors: relevance in copy-number alteration (CNA) analysis and fixed tissue samples [Poster presentation]. 13th Annual Meeting of the Belgian Society of Human Genetics, Bruxelles, Belgium.

CASTERMANS, E., GAILLEZ, S., & BOURS, V. (2013). Existe-t-il une predisposition genetique aux addictions ? Revue Médicale de Liège, 68 (5-6), 226-32.

Mascetti, L., Foret, A., Schrouff, J., Muto, V., DIDEBERG, V., Balteau, E., Degueldre, C., Phillips, C., Luxen, A., Collette, F., BOURS, V., & MAQUET, P. (2013). Concurrent Synaptic and Systems Memory Consolidation during Sleep. Journal of Neuroscience, 33 (24), 10182-10190. doi:10.1523/JNEUROSCI.0284-13.2013

Uwineza, A., PIERQUIN, G., GAILLEZ, S., JAMAR, M., CABERG, J.-H., & BOURS, V. (2013). Clinical, cytogenetic and molecular characterization of two cases of mosaic ring chromosome 13. Genetic Counseling, 24 (2), 193-200.

Wislet, S.* , Poulet, C.* , Neirinckx, V., Hennuy, B., Swingland, J., Laudet, E., Sommer, L., Shakhova, O., Bours, V., & Rogister, B. (October 2012). In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow. PLoS ONE, 7 (10), 46425. doi:10.1371/journal.pone.0046425
* These authors have contributed equally to this work.

Theatre, E., Frederix, K., Guilmain, W., Delierneux, C., Lecut, C., Bettendorff, L., BOURS, V., & Oury, C. (August 2012). Overexpression of CD39 in mouse airways promotes bacteria induced inflammation. Journal of Immunology, 189 (4), 1966-1974. doi:10.4049/jimmunol.1102600

LIBIOULLE, C., & BOURS, V. (2012). Les maladies complexes: l'importance de la genetique. Revue Médicale de Liège, 67 (5-6), 220-5.

Mutesa, L., JAMAR, M., PIERQUIN, G., & BOURS, V. (2012). A new 48, XXYY/47, XYY syndrome associated with multiple skeletal abnormalities, congenital heart disease and mental retardation. Indian Journal of Human Genetics, 18 (3), 352-5. doi:10.4103/0971-6866.108033

SCHEEN, A., & Bours, V. (2012). Maladies complexes: des interactions genes-environnement au probleme de sante publique. Revue Médicale de Liège, 67 (5-6), 217-9.

Tichomirowa, M., Lee, M., Barlier, A., Daly, A., Marinoni, I., Jaffrain-Rea, M.-L., Naves, L. A., Rodien, P., Rohmer, V., Faucz, F. R., Caron, P., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Yaneva, M., Guitelman, M., CASTERMANS, E., Verhaege, C., ... Beckers, A. (2012). Cyclin dependent kinase inhibitor (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenomas (FIPA) kindreds. Endocrine-Related Cancer, 19, 233-241. doi:10.1530/ERC-11-0362

Kroonen, J., Nassen, J., Boulanger, Y.-G., Provenzano, F., Capraro, V., Bours, V., Martin, D., Deprez, M., Robe, P., & Rogister, B. (2011). Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection. International Journal of Cancer, 129 (3), 574-585. doi:10.1002/ijc.25709

Lecut, C., Faccinetto, C., Evans, R. J., BOURS, V., & Oury, C. (2011). Lack of P2X1 ion channels increases endotoxemia associated coagulation and organ damage through neutrophil hyperresponsiveness. Journal of Thrombosis and Haemostasis, 9 (suppl S2).

Tichomirowa, M. A.* , Barlier, A.* , Daly, A.* , Jaffrain-Rea, M.-L., Ronchi, C., Yaneva, M., Urban, J. D., PETROSSIANS, P., Elenkova, A., Tabarin, A., Desailloud, R., Maiter, D., Schurmeyer, T., Cozzi, R., Theodoropoulou, M., Sievers, C., Bernabeu, I., Naves, L. A., Chabre, O., ... Beckers, A. (2011). High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. European Journal of Endocrinology, 165 (4), 509-15. doi:10.1530/EJE-11-0304
* These authors have contributed equally to this work.

Beckers, A., Tichomirowa, M., Pellegata, N., Barlier, A., Daly, A., Lee, M., Marinoni, I., Theodoropoulou, M., Verhaeghe, C., Tabarin, A., Rodien, P., Naves, L., Jaffrain-Rea, M.-L., Rohmer, V., Estour, B., Lecomte, P., Borson-Chazot, F., Penfornis, A., Thonnard, A.-S., ... Bours, V. (2010). Recherche de la mutation du gène CDKN1B dans les adénomes hypophysaires familiaux isolés (FIPA) : analyse de 86 familles. In 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010.

Daly, A., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raapana, A., Cazabat, L., De Menis, E., Montanana, C. F., Raverot, G., Weil, R. J., Sane, T., Maiter, D., Neggers, S., Yaneva, M., ... Beckers, A. (2010). Clinical characteristics and therapeutic responses in patients with Germ-line AIP mutations and pituitary adenomas : An international collaborative study. Journal of Clinical Endocrinology and Metabolism, 95 (11). doi:10.1210/jc.2009-2556

DELVENNE, P., Deprez, M., BISIG, B., JAMAR, M., Boniver, J., Bours, V., & HERENS, C. (2010). Fish and chips. Revue Médicale de Liège, 65 Spec no., 3-10.

VALDES SOCIN, H. G., Debray, F.-G., Parent, A.-S., Lebrethon, M.-C., Bourguignon, J.-P., Bours, V., & Beckers, A. (2010). Comment j'EXPLORE ... un hypogonadisme hypogonadotrope congenital isole. Revue Médicale de Liège, 65 (11), 634-41.

Beckers, A., Apetrii, P., Daly, A., Tichomirova, M., Vanbellinghen, J.-F., Georges, M., & Bours, V. (2009). Caractérisation clinique et génétique des adénomes hypophysaires familiaux isolés (FIPA). Revue Médicale de Liège, 64 (S1), 15-19.

Lecut, C., Frederix, K., Johnson, D. M., Deroanne, C., Thiry, M., Faccinetto, C., Marée, R., Evans, R. J., Volders, P. G., Bours, V., & Oury, C. (2009). P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation. Journal of Immunology. doi:10.4049/jimmunol.0804007

Mutesa, L., Azad, A. K., Verhaeghe, C., Segers, K., Vanbellinghen, J.-F., Ngendahayo, L., Rusingiza, E. K., Mutwa, P. R., Rulisa, S., Koulischer, L., Cassiman, J.-J., Cuppens, H., & Bours, V. (2009). Genetic Analysis of Rwandan Patients With Cystic Fibrosis-Like Symptoms: Identification of Novel Cystic Fibrosis Transmembrane Conductance Regulator and Epithelial Sodium Channel Gene Variants. CHEST, 135 (5), 1233-42. doi:10.1378/chest.08-2246

Robe, P., Martin, D., Nguyen-Khac, M.-T., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., & Bours, V. (2009). Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults. BMC Cancer, 9, 372. doi:10.1186/1471-2407-9-372

Lecut, C., Frederix, K., Johnson, D., Faccinetto, C., Volders, P., Bours, V., & Oury, C. (2008). Contribution of ATP-gated P2X1 ion channels to the control of neutrophil chemotaxis. Purinergic Signalling, 4, 30.

Mutesa, L., Pierquin, G., Janin, N., Segers, K., Thomee, C., Provenzi, M., & Bours, V. (2008). Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors. Cancer Genetics and Cytogenetics, 182 (1), 40-2. doi:10.1016/j.cancergencyto.2007.12.005

Mutesa, L., Pierquin, G., Segers, K., Vanbellinghen, J.-F., Gahimbare, L., & Bours, V. (2008). Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis. Journal of Tropical Pediatrics, 54 (5), 350-2. doi:10.1093/tropej/fmn034

Reenaers, C., Franchimont, N., Oury, C., Belaiche, J., Malaise, M., Bours, V., Theatre, E., Delvenne, P., & Louis, E. (2008). Sensitivity of intestinal fibroblasts to TNF-related apoptosis-inducing ligand-mediated apoptosis in Crohn's disease. Scandinavian Journal of Gastroenterology, 43, 1334-1345. doi:10.1080/00365520802200010

Theatre, E., Bours, V., & Oury, C. (2008). Airway P2X ion channels mediate IL-8 expression through CaMKII-dependent NF-kappaB activation. Purinergic Signalling.

Theatre, E., de Leval, L., Bettendorff, L., Bours, V., & Oury, C. (2008). Overexpression of airway CD39 in transgenic mice enhances lipopolysaccharide-induced inflammation. Purinergic Signalling, 4, 113.

Dideberg, V., Kristjansdottir, G., Milani, L., Libioulle, C., Sigurdsson, S., Louis, E., Wiman, A. C., Vermeire, S., Rutgeerts, P., Belaiche, J., Franchimont, D., Van Gossum, A., Bours, V., & Syvanen, A. C. (15 December 2007). An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Human Molecular Genetics, 16 (24), 3008-3016. doi:10.1093/hmg/ddm259

Naves, L. A., Daly, A., Vanbellinghen, J.-F., Casulari, L. A., Spilioti, C., Magalhaes, A. V., Azevedo, M. F., Giacomini, L. A., Nascimento, P. P., Nunes, R. O., Rosa, J. W. C., Jaffrain-Rea, M.-L., Bours, V., & Beckers, A. (October 2007). Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. European Journal of Endocrinology, 157 (4), 383-391. doi:10.1530/EJE-07-0533

Lambert, F., Heimann, P., Herens, C., Chariot, A., & Bours, V. (July 2007). Consultations in molecular diagnostics - A case of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia with a rare FIP1L1 breakpoint. Journal of Molecular Diagnostics, 9 (3), 414-419. doi:10.2353/jmoldx.2007.060196

Verhaeghe, C., Delbecque, K., de Leval, L., Oury, C., & Bours, V. (July 2007). Early inflammation in the airways of a cystic fibrosis foetus. Journal of Cystic Fibrosis, 6 (4), 304-308. doi:10.1016/j.jcf.2006.12.001

Daly, A., Vanbellinghen, J.-F., Khoo, S. K., Jaffrain-Rea, M.-L., Naves, L. A., Guitelman, M. A., Murat, A., Emy, P., Gimenez-Roqueplo, A.-P., Tamburrano, G., Raverot, G., Barlier, A., De Herder, W., Penfornis, A., Ciccarelli, E., Estour, B., Lecomte, P., Gatta, B., Chabre, O., ... Beckers, A. (May 2007). Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism, 92 (5), 1891-1896. doi:10.1210/jc.2006-2513

Mutesa, L., Pierquin, G., Cwiny-Ay, N., Buzizi, P., & Bours, V. (March 2007). Le syndrome de Hutchinson-Gilford (progeria): analyse clinique et moleculaire chez une patiente d'origine africaine. Revue Médicale de Liège, 62 (3), 155-8.

Barlier, A., Vanbellinghen, J.-F., Daly, A., Silvy, M., Jaffrain-Rea, M.-L., Trouillas, J., Tamagno, G., Cazabat, L., Bours, V., Brue, T., Enjalbert, A., & Beckers, A. (2007). Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 92 (5), 1952-5. doi:10.1210/jc.2006-2702

Faccinetto, C., Lecut, C., Jacobs, N., Bours, V., & Oury, C. (2007). P2X1 receptors as new regulators of neutrophil life span. Journal of Thrombosis and Haemostasis.

Louis, E., Bours, V., Dideberg, V., & Belaiche, J. (2007). Les maladies inflammatoires chroniques intestinales : de la génétique au traitement. Revue Médicale de Liège, 62, 47-51.

Robe, P., Nguyen-Khac, M.-T., Lambert, F., Lechanteur, C., Jolois, O., Ernst-Gengoux, P., Rogister, B., & Bours, V. (January 2007). Sufasalazine unveils a contact-independent HSV-TK/ganciclovir gene therapy bystander effect in malignant gliomas. International Journal of Oncology, 30 (1), 283-290. doi:10.3892/ijo.30.1.283

Verhaeghe, C., Tabruyn, S., Oury, C., Bours, V., & Griffioen, A. W. (2007). Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells. Biochemical and Biophysical Research Communications, 356 (3), 745-749. doi:10.1016/j.bbrc.2007.02.166

Benoit, V., de Moraes, E., Dar, N. A., Taranchon, E., Bours, V., Hautefeuille, A., Taniere, P., Chariot, A., Scoazec, J. Y., Gallo, C. V. D., Merville, M.-P., & Hainaut, P. (21 September 2006). Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene, 25 (42), 5708-5718. doi:10.1038/sj.onc.1209579

Close, P., Hawkes, N., Cornez, I., Creppe, C., Lambert, C. A., Rogister, B., Siebenlist, U., Merville, M.-P., Slaugenhaupt, S. A., Bours, V., Svejstrup, J. Q., & Chariot, A. (May 2006). Transcription impairment and cell migration defects in elongator-depleted cells: Implication for familial dysautonomia. Molecular Cell, 22 (4), 521-531. doi:10.1016/j.molcel.2006.04.017

Olivier, S., Close, P., Castermans, E., de Leval, L., Tabruyn, S., Chariot, A., Malaise, M., Merville, M.-P., Bours, V., & Franchimont, N. (May 2006). Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Molecular Pharmacology, 69 (5), 1615-1623. doi:10.1124/mol.105.020479

Bonif, M., Meuwis, M.-A., Close, P., Benoit, V., Heyninck, K., Chapelle, J.-P., Bours, V., Merville, M.-P., Piette, J., Beyaert, R., & Chariot, A. (2006). TNFa and IKKb-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKg and NF-kB activation. Biochemical Journal, 394, 593-603. doi:10.1042/BJ20051659

Faccinetto, C., Lecut, C., Greimers, R., Bours, V., & Oury, C. (2006). New role for ATP P2X1 receptors in the control of neutrophil apoptosis and respiratory burst activity. Blood, 108 (11, Part 1), 1647.

Turkheimer, F. E., Roncaroli, F., Hennuy, B., Herens, C., Nguyen Khac, M.-T., Martin, D., Evrard, A., Bours, V., Boniver, J., & Deprez, M. (2006). Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas. BMC Bioinformatics, 7, 526. doi:10.1186/1471-2105-7-526

Dideberg, V., & Bours, V. (December 2005). Integration de la pharmacogenetique dans la pratique medicale. Revue Médicale de Liège, 60 (12), 918-22.

Lechanteur, C., Jacobs, N., Greimers, R., Benoit, V., Deregowski, V., Chariot, A., Merville, M.-P., & Bours, V. (03 March 2005). Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis. Oncogene, 24 (10), 1788-1793. doi:10.1038/sj.onc.1208436

De Seny, D.* , Fillet, M.* , Meuwis, M.-A., Geurts, P., Lutteri, L., Ribbens, C., Bours, V., Wehenkel, L., Piette, J., Malaise, M., & Merville, M.-P. (2005). Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis and Rheumatism, 52 (12), 3801-12. doi:10.1002/art.21607
* These authors have contributed equally to this work.

Olivier, S., Fillet, M., Malaise, M., Piette, J., Bours, V., Merville, M.-P., & Franchimont, N. (2005). Sodium nitroprusside-induced osteoblast apoptosis is mediated by long chain ceramide and is decreased by raloxifene. Biochemical Pharmacology, 69 (6), 891-901. doi:10.1016/j.bcp.2004.11.030

Robe, P., Nguyen-Khac, M.-T., Jolois, O., Rogister, B., Merville, M.-P., & Bours, V. (2005). Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells. BMC Cancer, 5, 32. doi:10.1186/1471-2407-5-32

Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (January 2005). Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation [letter to the editor]. Trends in Biochemical Sciences, 30 (1), 43-52. doi:10.1016/j.tibs.2004.11.009

Franchimont, N., Reenaers, C., Lambert, C., Belaiche, J., Bours, V., Malaise, M., Delvenne, P., & Louis, E. (December 2004). Increased expression of receptor activator of NF-kappa B ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clinical and Experimental Immunology, 138 (3), 491-498. doi:10.1111/j.1365-2249.2004.02643.x

Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (December 2004). Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity. Cell Cycle, 3 (12), 1498-1501. doi:10.4161/cc.3.12.1328

Viatour, P., Dejardin, E., Warnier, M., Lair, F., Claudio, E., Bureau, F., Marine, J. C., Merville, M.-P., Maurer, U., Green, D., Piette, J., Siebenlist, U., Bours, V., & Chariot, A. (08 October 2004). GSK3-Mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Molecular Cell, 16 (1), 35-45. doi:10.1016/j.molcel.2004.09.004

Adam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Haterte, S., Goffin, V., Nguyen, T. L.-A., Gloire, G., Carrard, G., Friguet, B., de Launoit, Y., Burny, A., Bours, V., Piette, J., & Van Lint, C. (August 2004). Erratum: Potentiation of tumor necrosis factor-induced NF-κb activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of IκBα (Molecular and Cellular Biology (2003) 23, 17 (6200-6209)). Molecular and Cellular Biology, 24 (15), 6890. doi:10.1128/MCB.24.15.6890.2004

Benoit, V., Relic, B., de Leval, L., Chariot, A., Merville, M.-P., & Bours, V. (February 2004). Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2. Oncogene, 23 (8), 1631-1635. doi:10.1038/sj.onc.1207295

Benoit, V., Chariot, A., Delacroix, L., Deregowski, V., Jacobs, N., Merville, M.-P., & Bours, V. (2004). Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappa B through c-FLIP-L expression. Cancer Research, 64 (8), 2684-2691. doi:10.1158/0008-5472.CAN-03-2914

Robe, P., Bentires-Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.-T. N., Jolois, O., Erkmen, K., Merville, M.-P., Black, P. M., & Bours, V. (2004). In vitro and in vivo activity of the nuclear factor-kappa B inhibitor sulfasalazine in human glioblastomas. Clinical Cancer Research, 10 (16), 5595-603. doi:10.1158/1078-0432.CCR-03-0392

Viatour, P., Legrand-Poels, S., van Lint, C., Warnier, M., Merville, M.-P., Gielen, J.-L., Piette, J., Bours, V., & Chariot, A. (21 November 2003). Cytoplasmic I kappa B alpha increases NF-kappa B-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. Journal of Biological Chemistry, 278 (47), 46541-46548. doi:10.1074/jbc.M306381200

Adam, E., Quivy, V., Bex, F., Chariot, A., Collette, Y., Vanhulle, C., Haterte, S., Goffin, V., Nguyen, T. L.-A., Gloire, G., Carrard, G., Friguet, B., de Launoit, Y., Burny, A., Bours, V., Piette, J., & Van Lint, C. (September 2003). Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. Molecular and Cellular Biology, 23 (17), 6200-6209. doi:10.1128/MCB.23.17.6200-6209.2003

Viatour, P., Bentires-Alj, M., Chariot, A., Deregowski, V., de Leval, L., Merville, M.-P., & Bours, V. (July 2003). NF-kappa B2/p100 induces Bcl-2 expression. Leukemia, 17 (7), 1349-1356. doi:10.1038/sj.leu.2402982

Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7

Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M.-P., & Bours, V. (2003). NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 22, 90-97. doi:10.1038/sj.onc.1206056

Fillet, M., Bentires-Alj, M., Deregowski, V., Greimers, R., Gielen, J.-L., Piette, J., Bours, V., & Merville, M.-P. (2003). Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochemical Pharmacology, 65 (10), 1633-42. doi:10.1016/S0006-2952(03)00125-4

Quivy, V., Adam, E., Collette, Y., Demonte, D., Chariot, A., Vanhulle, C., Berkhout, B., Castellano, R., de Launoit, Y., Burny, A., Piette, J., Bours, V., & Van Lint, C. (November 2002). Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappa B and inhibitors of deacetylases: Potential perspectives for the development of therapeutic strategies. Journal of Virology, 76 (21), 11091-11103. doi:10.1128/JVI.76.21.11091-11103.2002

Polus, M., Bours, V., Jerusalem, G., Sautois, B., & Fillet, G. (July 2002). Comment je traite.... Le cancer avance du pancreas par une approche innovante dirigee contre les nouvelles cibles. Revue Médicale de Liège, 57 (7), 428-32.

Detry, O., Detroz, B., Preud'Homme, L., Bours, V., Honore, P., & Jacquet, N. (January 2001). Radiofrequency ablation of liver tumors: short term evaluation. Acta Gastro-Enterologica Belgica, 64 (1), 11.

Lechanteur, C., Delvenne, P., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J., Merville, M.-P., & Bours, V. (September 2000). Combined Suicide and Cytokine Gene Therapy for Peritoneal Carcinomatosis. Gut, 47 (3), 343-8. doi:10.1136/gut.47.3.343

Bentires-Alj, M., Hellin, A.-C., Lechanteur, C., Princen, F., Lopez Y Cadenas, M., Fillet, G., Gielen, J.-L., Merville, M.-P., & Bours, V. (January 2000). Cytosine Deaminase Suicide Gene Therapy for Peritoneal Carcinomatosis. Cancer Gene Therapy, 7 (1), 20-6. doi:10.1038/sj.cgt.7700093

Bonnet, C., Jerusalem, G., Bours, V., & Fillet, G. (2000). Approches thérapeutiques du cancer ovarien. Médecine et Hygiène, 58, 1625-1628.

Chariot, A., Gielen, J., Merville, M.-P., & Bours, V. (December 1999). The homeodomain-containing proteins: an update on their interacting partners. Biochemical Pharmacology, 58, 1851-1857. doi:10.1016/S0006-2952(99)00234-8

Chariot, A., Princen, F., Gielen, J., Merville, M.-P., Franzoso, G., Brown, K., Siebenlist, U., & Bours, V. (10 February 1999). Ikappab-Alpha Enhances Transactivation by the Hoxb7 Homeodomain-Containing Protein. Journal of Biological Chemistry, 274 (9), 5318-25. doi:10.1074/jbc.274.9.5318

Chariot, A., Van Lint, C., Chapelier, M., Gielen, J., Merville, M.-P., & Bours, V. (1999). CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene, 18, 4007-4012. doi:10.1038/sj.onc.1202776

Jerusalem, G., Bours, V., & Fillet, G. (1999). Actualités thérapeutiques dans le traitement du cancer colorectal. Médecine et Hygiène, 57, 1552-1554.

Princen, F., Lechanteur, C., Lopez Y Cadenas, M., Rocoux, G., Detroz, B., Gielen, J.-L., Fillet, G., Merville, M.-P., & Bours, V. (August 1998). Repeated Cycles of Retrovirus-Mediated Hsvtk Gene Transfer Plus Ganciclovir Increase Survival of Rats with Peritoneal Carcinomatosis. Gene Therapy, 5 (8), 1054-60. doi:10.1038/sj.gt.3300710

Defechereux-Thibaut de Maisières, P., Baudoux-Tebache, L., Merville, M.-P., Rentier, B., Bours, V., & Piette, J. (May 1998). Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region. Journal of Biological Chemistry, 273 (22), 13636-13644.

Dejardin, E., Deregowski, V., GREIMERS, R., Cai, Z., Chouaib, S., Merville, M.-P., & BOURS, V. (1998). Regulation of major histocompatibility complex class I expression by NF-kB-related proteins in breast cancer cells. Oncogene. doi:10.1038/sj.onc.1201879

Lechanteur, C., Princen, F., Lo Bue, S., Detroz, B., Fillet, G., Gielen, J., Bours, V., & Merville, M.-P. (1998). Hsv-1 Thymidine Kinase Gene Therapy for Peritoneal Carcinomatosis. Advances in Experimental Medicine and Biology, 451, 115-9. doi:10.1007/978-1-4615-5357-1_18

Hermanne, J.-P., TASSIN, F., Bours, V., & Fillet, G. (1996). Intérêt de l'acide rétinoïque "tous trans" dans le traitement de la leucémie aiguë promyélocytaire. Médecine et Hygiène, 54, 1472-1479.

Legrand-Poels, S., Bours, V., Piret, B., Pflaum, M., Epe, B., Rentier, B., & Piette, J. (24 March 1995). Transcription factor NF-kB is activated by photosensitization generating oxidative DNA damages. Journal of Biological Chemistry, 270 (12), 6925-6934. doi:10.1074/jbc.270.12.6925

Jerusalem, G., Detroz, B., Herman, P., Dohogne, A., Closon, M. T., Jacquet, N., Honoré, P., Bruyninx, L., Fillet, G., Fassotte, M.-F., Bours, V., & Lipcsei, G. (1995). Approche thérapeutique du cancer épithélial de l'ovaire au CHU Sart Tilman : Conclusions de la réunion interdisciplinaire du 22 mars 1995. Revue Médicale de Liège, 50, 469-471.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502.

Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N